Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
140-82-9
17626-34-5
23978-09-8
31249-95-3
23978-55-4
70384-51-9
2100306-69-0 | N-(T-Butyl ester-peg2)-n-bis(peg2-propargyl) | AA019E93 | MFCD30723248
2144775-48-2 | D-Biotin-PEG6-Thalidomide | AA019EEB | MFCD31561114
1133325-57-1 | tert-Butyl 7-oxo-6-((S)-1-phenylethyl)-2,6-diazabicyclo[3.2.0]heptane-2-carboxylate | AA019EHO | MFCD29917035
349405-03-4 | 4-bromo-N-(3,4-difluorophenyl)benzenesulfonamide | AA019EKX | MFCD01215121
926649-64-1 | Cis-5-(Tert-Butoxycarbonyl)-4,5,6,6A-Tetrahydro-3Ah-Pyrrolo[3,4-D]Isoxazole-3-Carboxylic Acid | AA019ENU | MFCD31656848
1823581-76-5 | 2-(2-Methyl-1,3-dioxolan-2-yl)-1h-imidazole | AA019EQU | MFCD28142369
721968-63-4 | 2,3-Dihydro-1h-inden-5-ylmethanamine hydrochloride | AA019EUF | MFCD11813965
1350296-64-8 | 2,4-dimethylbenzo[h]quinolin-10-ol | AA019EXK | MFCD31555249
55721-31-8 | Salinomycin sodium salt | AA019FPW | MFCD00145265
1523530-71-3 | (3S,4R)-3-Methyltetrahydro-2H-pyran-4-amine hydrochloride | AA019FYI | MFCD27988013